Press Releases IO Biotech, Inc.

Equities

IOBT

US4497781090

Delayed Nasdaq Other stock markets 02:49:20 2024-05-28 pm EDT			5-day change	1st Jan Change
1.26 ^USD	-0.79%		-5.62%	-32.98%

May. 15	HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating	MT
May. 14	IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IO Biotech to Present at Jefferies Global Healthcare Conference	May. 23	AQ
IO Biotech : Corporate Deck May 2024	May. 16	PU
IO Biotech : Corporate Deck May 2024	May. 14	PU
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	May. 14	AQ
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	Apr. 24	AQ
IO Biotech : Corporate Deck April 2024	Apr. 17	PU
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	Apr. 15	AQ
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	Apr. 09	AQ
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	Apr. 05	AQ
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	Mar. 06	AQ
IO Biotech : Corporate Deck March 2024	Mar. 05	PU
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	Mar. 05	AQ
IO Biotech to Present at 44th Annual Cowen Health Care Conference	Feb. 26	AQ
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial	Dec. 21	AQ
Basal Cell Carcinoma Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 (Updated)	Dec. 20	AQ
IO Biotech Announces 2023 Third Quarter Results	Nov. 13	AQ
IO Biotech Appoints Helen Collins, MD, to its Board of Directors	Nov. 13	AQ
IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma	Nov. 10	AQ
IO Biotech Announces Participation in Upcoming Investor Conferences	Nov. 08	AQ
IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	Nov. 01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IO Biotech, Inc.

Equities

IOBT

US4497781090

Press Releases

Filters